1
4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ
Condition(s):Ductal Breast Carcinoma in Situ; Estrogen Receptor-positive Breast CancerLast Updated:July 21, 2015Completed
Hydroxytamoxifen: 16 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women
Condition(s):Breast CancerLast Updated:May 30, 2012Completed
3
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
Condition(s):Ductal Breast Carcinoma In Situ; Estrogen Receptor PositiveLast Updated:December 21, 2020Recruiting
4
Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ
Condition(s):Atypical Hyperplasia; Lobular Carcinoma in SituLast Updated:October 8, 2020Not yet recruiting
5
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast
Condition(s):Mammographically Dense BreastLast Updated:February 5, 2020Recruiting
6
Trial of 4-OHT Gel in Women Aimed at Reducing Dense Breast Tissue
Condition(s):Mammographic Breast DensityLast Updated:July 1, 2019Terminated
7
Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women
Condition(s):Cyclic Breast Pain, Cyclic MastalgiaLast Updated:July 15, 2013Completed
8
Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen
Condition(s):Breast CancerLast Updated:July 8, 2019Unknown status
9
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
Condition(s):Cancer Survivor; Ductal Breast Carcinoma In Situ; Invasive Breast CarcinomaLast Updated:December 4, 2020Recruiting
10
Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients
Condition(s):Breast Cancer; DCISLast Updated:October 26, 2020Recruiting